VCM
VIR icon

Versant Capital Management’s Vir Biotechnology VIR Stock Holding History

Versant Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Sell
2,690
-209
-7% -$1.99K ﹤0.01% 1757
2026
Q1 		$26K Buy
2,899
+1,282
+79% +$10.2K ﹤0.01% 1668
2025
Q4 		$9.75K Sell
1,617
-50
-3% -$298 ﹤0.01% 2002
2025
Q3 		$9.52K Buy
1,667
+24
+1% +$123 ﹤0.01% 1960
2025
Q2 		$8.28K Buy
1,643
+934
+132% +$5.01K ﹤0.01% 1972
2025
Q1 		$4.59K Buy
+709
New +$6.3K ﹤0.01% 2057
2024
Q4 		– Sell
-391
Closed -$2.93K – 2431
2024
Q3 		$2.93K Sell
391
-1,763
-82% -$15.3K ﹤0.01% 1459
2024
Q2 		$19.2K Buy
2,154
+1,895
+732% +$18.2K ﹤0.01% 737
2024
Q1 		$2.62K Buy
259
+38
+17% +$387 ﹤0.01% 1263
2023
Q4 		$2.22K Buy
221
+23
+12% +$210 ﹤0.01% 1255
2023
Q3 		$1.85K Buy
198
+84
+74% +$1.2K ﹤0.01% 1336
2023
Q2 		$2.8K Buy
114
+21
+23% +$527 ﹤0.01% 1248
2023
Q1 		$2.16K Hold
93
– – ﹤0.01% 1258
2022
Q4 		$2.35K Sell
93
-15
-14% -$368 ﹤0.01% 1095
2022
Q3 		$2K Buy
108
+71
+192% +$1.8K ﹤0.01% 1138
2022
Q2 		$1K Buy
37
+25
+208% +$584 ﹤0.01% 1373
2022
Q1 		$0 Buy
+12
New +$356 ﹤0.01% 1647

Other funds holding VIR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FG
Foster Group West Des Moines, Iowa $3.76B AUM 21.29% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Versant Capital Management's VIR Position: Q2 2026 in Review

Versant Capital Management reduced its Vir Biotechnology (VIR) stake by 7.2% in Q2 2026, selling an estimated $1.99K and leaving 2,690 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Versant Capital Management first reported a position in VIR in Q1 2022 and has held it in 17 quarters since. 14 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Versant Capital Management held 2,690 shares of Vir Biotechnology worth $27.4K as of Q2 2026.
  • Versant Capital Management sold 209 Vir Biotechnology shares in Q2 2026, an estimated $1.99K.
  • Vir Biotechnology made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1757 holding.
  • Versant Capital Management first reported a position in Vir Biotechnology in Q1 2022 and has held it in 17 quarters since.
  • 14 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.